Purchase Order HHSN268201700267A
Award Date 8/9/17
Potential Completion Date 8/16/22
Potential Value $701K
Federal Agency
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $51,828.84 firm-fixed-price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance of Fortessa flow cytometer analyzers. The contract has a period of performance through January 12, 2026. BD is a global medical technology company that provides a range of biomedical research and clinical instruments, including flow cytometers, as well as...
- This firm fixed price purchase order was awarded by the National Heart Lung and Blood Institute, a civilian agency of the U.S. government, to Becton, Dickinson and Company (BD) for LSRFortessa maintenance services. The $219,675 contract has a ceiling value and a performance period ending on September 30, 2025. The award does not utilize a set-aside designation. BD, a global medical technology company, will provide maintenance services for the agency's LSRFortessa instruments, which are...
- This is a $199,847.40 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Becton, Dickinson and Company (BD) for the maintenance of FACSYMPHONY A5 instruments. The contract has an ultimate completion date of September 30, 2025. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and clinical applications, including flow cytometry, cell imaging, and genomics...
- This is a $460,479.60 firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for the service and maintenance of a BD FACSymphony S6 cell sorter. The contract has a period of performance through June 18, 2027 and is not designated as a set-aside. BD, a global medical technology company, will provide preventive maintenance, emergency repairs, software...
- This is a $17,118.00 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) to provide a service contract to maintain a flow cytometer. The contract period of performance is June 2, 2025 through June 1, 2026. No set-aside designation was used for this award. BD is a global medical technology company that develops, manufactures, and sells medical devices,...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a delivery order valued at $53,205.12 to Becton, Dickinson and Company (BD Biosciences) on January 1, 2026, for maintenance coverage of its LSRFortessa flow cytometry system and throughput sampler. This firm fixed-price contract, which serves as a child delivery order under a larger indefinite delivery vehicle, will be performed in San Jose, California and is scheduled for completion by December 31, 2026. The award was made without...
- Becton, Dickinson and Company (BD) was awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Heart, Lung and Blood Institute to provide maintenance services for a BD Biosciences Fortessa flow cytometer. The potential value of this contract is $147,863.40. No set-aside designation was used for this award. Performance will occur in Bethesda, Maryland and continue through January 31, 2025. This award is associated with the...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Becton, Dickinson And Company (BD) on January 10, 2020 for the maintenance of a BD Fortessa flow cytometer analyzer. The contract has a potential value of $223,064.40 and a completion date of January 12, 2025. The place of performance is Bethesda, Maryland. BD is a global medical technology company that provides a...
- This is a firm fixed-price purchase order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through its BDB Division and BD Biosciences brand. The $21,900.48 contract is for a service contract to maintain the NHLBI's FACS Fortessa X-20 SORP flow cytometry instrument. This contract does not have a set-aside designation, indicating it was competed on a full and open basis. BD, a...
- This is a $379,912 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD) for an LSRFORTESSA X20 flow cytometer. The contract has no set-aside designation and was awarded on July 19, 2016, with a completion date of August 26, 2016. BD is a global medical technology company that provides a wide range of instruments, reagents, and services to...